scholarly journals Latent Class Analysis: Insights about design and analysis of schistosomiasis diagnostic studies

2021 ◽  
Vol 15 (2) ◽  
pp. e0009042
Author(s):  
Artemis Koukounari ◽  
Haziq Jamil ◽  
Elena Erosheva ◽  
Clive Shiff ◽  
Irini Moustaki

Various global health initiatives are currently advocating the elimination of schistosomiasis within the next decade. Schistosomiasis is a highly debilitating tropical infectious disease with severe burden of morbidity and thus operational research accurately evaluating diagnostics that quantify the epidemic status for guiding effective strategies is essential. Latent class models (LCMs) have been generally considered in epidemiology and in particular in recent schistosomiasis diagnostic studies as a flexible tool for evaluating diagnostics because assessing the true infection status (via a gold standard) is not possible. However, within the biostatistics literature, classical LCM have already been criticised for real-life problems under violation of the conditional independence (CI) assumption and when applied to a small number of diagnostics (i.e. most often 3-5 diagnostic tests). Solutions of relaxing the CI assumption and accounting for zero-inflation, as well as collecting partial gold standard information, have been proposed, offering the potential for more robust model estimates. In the current article, we examined such approaches in the context of schistosomiasis via analysis of two real datasets and extensive simulation studies. Our main conclusions highlighted poor model fit in low prevalence settings and the necessity of collecting partial gold standard information in such settings in order to improve the accuracy and reduce bias of sensitivity and specificity estimates.

2021 ◽  
Author(s):  
Matthew R. Schofield ◽  
Michael J. Maze ◽  
John A. Crump ◽  
Matthew P. Rubach ◽  
Renee Galloway ◽  
...  

2016 ◽  
Vol 74 ◽  
pp. 158-166 ◽  
Author(s):  
Maarten van Smeden ◽  
Daniel L. Oberski ◽  
Johannes B. Reitsma ◽  
Jeroen K. Vermunt ◽  
Karel G.M. Moons ◽  
...  

2021 ◽  
Vol 40 (22) ◽  
pp. 4770-4771
Author(s):  
Matthew R. Schofield ◽  
Michael J. Maze ◽  
John A. Crump ◽  
Matthew P. Rubach ◽  
Renee L. Galloway ◽  
...  

2021 ◽  
Author(s):  
Sahar Saeed ◽  
Sheila F O'Brein ◽  
Kento Abe ◽  
QiLong Yi ◽  
Bhavisha Rathod ◽  
...  

Background: Multiple anti-SARS-CoV-2 immunoassays are available, but no gold standard exists. We assessed four assays using various methodological approaches to estimate SARS-COV-2 seroprevalence during the first COVID-19 wave in Canada. Methods: This serial cross-sectional study was conducted using plasma samples from healthy blood donors between April-September 2020. Qualitative assessment of SARS-CoV-2 IgG antibodies was based on four assays: Abbott Architect SARS-Cov-2 IgG assay (target nucleocapsid) (Abbott-NP) and three in-house IgG ELISA assays (target spike glycoprotein (Spike), spike receptor binding domain (RBD), and nucleocapsid (NP)). Seroprevalence was estimated using multiple composite reference standards (CRS) and by a series of Bayesian Latent Class Models (BLCM) (using uninformative, weakly, and informative priors). Results: 8999 blood samples were tested. The Abbott-NP assay consistently estimated seroprevalence to be lower than the ELISA-based assays. Discordance between assays was common, 13 unique diagnostic phenotypes were observed. Only 32 samples (0.4%) were positive by all four assays. BLCM using uninformative priors predicted seroprevalence increased from 0.7% (95% credible interval (CrI); 0.4, 1.0%) in April/May to 0.8% (95% CrI 0.5, 1.2%) in June/July to 1.1% (95% CrI 0.7, 1.6) in August/September. Results from CRS were very similar to the BLCM. Assay characteristics varied considerably over time. Overall spike had the highest sensitivity (89.1% (95% CrI 79.2, 96.9%), while the sensitivity of the Abbott-NP assay waned from 65.3% (95% CrI 43.6, 85.0%) in April/May to 45.9% (95% CrI 27.8, 65.6) by August/September. Discussion: We found low SARS-CoV-2 seroprevalence rates at the end of the first wave and estimates derived from single assays may be biased.


2017 ◽  
Vol 10 (1) ◽  
Author(s):  
Belen Otero-Abad ◽  
Maria Teresa Armua-Fernandez ◽  
Peter Deplazes ◽  
Paul R. Torgerson ◽  
Sonja Hartnack

2017 ◽  
Vol 28 (2) ◽  
pp. 419-431 ◽  
Author(s):  
Xiaonan Xue ◽  
Maja Oktay ◽  
Sumanta Goswami ◽  
Mimi Y Kim

The paper is motivated by the problem of comparing the accuracy of two molecular tests in detecting genetic mutations in tumor samples when there is no gold standard test. Commonly used sequencing methods require a large number of tumor cells in the tumor sample and the proportion of tumor cells with mutation positivity to be above a threshold level whereas new tests aim to reduce the requirement for number of tumor cells and the threshold level. A new latent class model is proposed to compare these two tests in which a random variable is used to represent the unobserved proportion of mutation positivity so that these two tests are conditionally dependent; furthermore, an independent random variable is included to address measurement error associated with the reading from each test, while existing latent class models often assume conditional independence and do not allow measurement error. In addition, methods for calculating the sample size for a study that is sufficiently powered to compare the accuracy of two molecular tests are proposed and compared. The proposed methods are then applied to a study which aims to compare two molecular tests for detecting EGFR mutations in lung cancer patients.


2019 ◽  
Vol 29 (4) ◽  
pp. 1112-1128
Author(s):  
Chunling Wang ◽  
Xiaoyan Lin ◽  
Kerrie P Nelson

The diagnostic accuracy of a test or rater has a crucial impact on clinical decision making. The assessment of diagnostic accuracy for multiple tests or raters also merits much attention. A Bayesian hierarchical conditional independence latent class model for estimating sensitivities and specificities for a large group of tests or raters is proposed, which is applicable to both with-gold-standard and without-gold-standard situations. Through the hierarchical structure, not only are the sensitivities and specificities of individual tests estimated, but also the diagnostic performance of the whole group of tests. For a small group of tests or raters, the proposed model is further extended by introducing pairwise covariances between tests to improve the fitting and to allow for more modeling flexibility. Correlation residual analysis is applied to detect any significant covariance between multiple tests. Just Another Gibbs Sampler (JAGS) implementation is efficiently adopted for both models. Three real data sets from literature are analyzed to explicitly illustrate the proposed methods.


Sign in / Sign up

Export Citation Format

Share Document